Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Baxter Aurora dialysis system.

Thomas D Kelly1

  • 1Baxter Healthcare Inc., 3925 Gateway Center Boulevard, Pinellas Park, FL 33782, USA. tom_d_kelly@baxter.com

Seminars in Dialysis
|March 27, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Intracardiac Vascular Access for Hemodialysis Despite Associated Ascending Aortic Aneurysm.

Seminars in dialysis·2026
Same journal

Measures of Equivalent Hemodialysis Urea Clearance and Their Proposed Utility for Monitoring Adequacy.

Seminars in dialysis·2026
Same journal

Risk of Serious Adverse Events and Death With Low-Dose Methotrexate Versus Hydroxychloroquine in Adults Receiving Dialysis.

Seminars in dialysis·2026
Same journal

Severe Hematoma Following Initial Arteriovenous Fistula Puncture in a Hemodialysis Patient, Emphasizing Thoracic Outlet Syndrome: A Case Report.

Seminars in dialysis·2026
Same journal

Phosphate Kinetic Modeling in Patients Treated With Hemodialysis or Hemodiafiltration: A Prospective, Multicenter, Cross-Sectional Study.

Seminars in dialysis·2026
Same journal

Impact of Expanded Hemodialysis on Inflammation and Iron Metabolism in Chronic Hemodialysis Patients.

Seminars in dialysis·2026
See all related articles

The Baxter Aurora dialysis system offers flexible renal therapy options, including daily and nocturnal treatments, with an intuitive interface for ease of use and patient safety. This system supports various dialysis modalities for enhanced patient care.

Area of Science:

  • Nephrology
  • Biomedical Engineering

Background:

  • Increasing focus on the benefits of more frequent dialysis treatments.
  • Need for adaptable dialysis systems to accommodate diverse patient needs and therapy schedules.

Purpose of the Study:

  • To introduce the Baxter Aurora dialysis system and highlight its features.
  • To demonstrate the system's flexibility in prescribing various dialysis modalities.
  • To emphasize the system's user-friendly design and safety features for hemodialysis patients.

Main Methods:

  • The Baxter Aurora system offers flexible therapy prescriptions: short daily, long nocturnal, hemodialysis, hemofiltration, and online hemodiafiltration.
  • Features a self-prompting touchscreen interface on a movable arm for comfortable operation.
  • Includes an automatic treatment setup mode and a hardware key to simplify operation by presenting only prescribed options.

Related Experiment Videos

  • Incorporates an automatic self-test before dialysis and a self-disinfecting feature post-treatment.
  • Main Results:

    • The system provides maximum flexibility in therapy prescription, accommodating various dialysis modalities.
    • User interface and automatic setup modes enhance ease of use, reducing potential confusion.
    • Integrated safety features, including pre-dialysis self-tests and restricted access to disinfection menus during treatment, ensure patient safety.
    • Remote monitoring capabilities and detailed machine history logging facilitate efficient servicing and support.

    Conclusions:

    • The Baxter Aurora dialysis system is a versatile and user-friendly platform for renal therapy.
    • It supports a wide range of dialysis treatments, enhancing flexibility for healthcare providers and patients.
    • The system's design prioritizes ease of use, safety, and remote monitoring, supported by Baxter's infrastructure.